135 related articles for article (PubMed ID: 35973378)
1. The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.
David G; Reboutier D; Deschamps S; Méreau A; Taylor W; Padilla-Parra S; Tramier M; Audic Y; Paillard L
Biochem Biophys Res Commun; 2022 Oct; 626():79-84. PubMed ID: 35973378
[TBL] [Abstract][Full Text] [Related]
2. CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells.
Xia H; Chen D; Wu Q; Wu G; Zhou Y; Zhang Y; Zhang L
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):911-921. PubMed ID: 28733224
[TBL] [Abstract][Full Text] [Related]
3. Distribution of alternative untranslated regions within the mRNA of the CELF1 splicing factor affects its expression.
Kajdasz A; Niewiadomska D; Sekrecki M; Sobczak K
Sci Rep; 2022 Jan; 12(1):190. PubMed ID: 34996980
[TBL] [Abstract][Full Text] [Related]
4. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72.
Hönig A; Auboeuf D; Parker MM; O'Malley BW; Berget SM
Mol Cell Biol; 2002 Aug; 22(16):5698-707. PubMed ID: 12138182
[TBL] [Abstract][Full Text] [Related]
5. Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3.
Vela E; Hilari JM; Roca X; Muñoz-Mármol AM; Ariza A; Isamat M
RNA; 2007 Dec; 13(12):2312-23. PubMed ID: 17940137
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.
Wang ET; Ward AJ; Cherone JM; Giudice J; Wang TT; Treacy DJ; Lambert NJ; Freese P; Saxena T; Cooper TA; Burge CB
Genome Res; 2015 Jun; 25(6):858-71. PubMed ID: 25883322
[TBL] [Abstract][Full Text] [Related]
8. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
[TBL] [Abstract][Full Text] [Related]
9. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
Watermann DO; Tang Y; Zur Hausen A; Jäger M; Stamm S; Stickeler E
Cancer Res; 2006 May; 66(9):4774-80. PubMed ID: 16651431
[TBL] [Abstract][Full Text] [Related]
10. SR protein expression and CD44 splicing pattern in human breast tumours.
Pind MT; Watson PH
Breast Cancer Res Treat; 2003 May; 79(1):75-82. PubMed ID: 12779084
[TBL] [Abstract][Full Text] [Related]
11. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
[TBL] [Abstract][Full Text] [Related]
12. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
Yu Q; Toole BP
J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
[TBL] [Abstract][Full Text] [Related]
13. Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle.
Blech-Hermoni Y; Dasgupta T; Coram RJ; Ladd AN
PLoS One; 2016; 11(2):e0149061. PubMed ID: 26866591
[TBL] [Abstract][Full Text] [Related]
14. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
[TBL] [Abstract][Full Text] [Related]
15. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
Loh TJ; Cho S; Moon H; Jang HN; Williams DR; Jung DW; Kim IC; Ghigna C; Biamonti G; Zheng X; Shen H
Biochim Biophys Acta; 2015 Jun; 1849(6):743-50. PubMed ID: 25623890
[TBL] [Abstract][Full Text] [Related]
16. Nuclear hyaluronidase 2 drives alternative splicing of
Midgley AC; Oltean S; Hascall V; Woods EL; Steadman R; Phillips AO; Meran S
Sci Signal; 2017 Nov; 10(506):. PubMed ID: 29162741
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors.
Fleming VA; Geng C; Ladd AN; Lou H
BMC Mol Biol; 2012 Dec; 13():35. PubMed ID: 23227900
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.
Cappellari M; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Saarikettu J; Silvennoinen O; Sette C
Oncogene; 2014 Jul; 33(29):3794-802. PubMed ID: 23995791
[TBL] [Abstract][Full Text] [Related]
19. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
[TBL] [Abstract][Full Text] [Related]
20. Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR.
Zhang W; Liu H; Han K; Grabowski PJ
RNA; 2002 May; 8(5):671-85. PubMed ID: 12022233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
